Two new studies published in JAMA Neurology reveal that GLP-1 receptor agonists, like Ozempic and Trulicity, may ...

Discover most of the FDA-approved drugs from the medical speciality of Neurology. This page can serve as a valuable information guide for healthcare providers and patients seeking detailed drug ...

The Food and Drugs Administration of Punjab Government last year seized drug formulations containing pregabalin worth Rs 5.97 ...

Drugs acting on the cholinergic system can improve or worsen cognitive abilities, and their effects are particularly pronounced in frail elderly individuals and patients with Alzheimer disease.

There are several ASX biotech companies developing drugs to treat complex neurological conditions Global neurological ...

According to Data Bridge Market Research, the global neurological disorder drugs market was valued at $79.4 million in 2021, with a forecasted compound annual growth rate (CAGR) of 5.9% through 2029.

The study outlines the market potential for neurology medications for both now and in the future. It also provides a thorough examination of the market's drivers, constraints, and pipeline ...

Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for ...